2019
DOI: 10.1016/j.bbi.2019.05.029
|View full text |Cite
|
Sign up to set email alerts
|

Astrocytes in multiple sclerosis and experimental autoimmune encephalomyelitis: Star-shaped cells illuminating the darkness of CNS autoimmunity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
43
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 53 publications
(45 citation statements)
references
References 257 publications
1
43
0
1
Order By: Relevance
“…Glutamate is the central nervous system's main excitatory neurotransmitter, but when present in excess it triggers a chain of negative reactions. Glutamate neurotoxicity's involvement in the pathogenesis of demyelination and neuronal and synaptic damage in MS has been demonstrated on numerous occasions [56]; activated immune cells and astrocytes release large amounts of glutamate, damaging myelin sheaths and axons [57,58], and changes in glutamate levels in these areas have been associated with the later stages of MS, episodes, and secondary progression. An imbalance in glutamate receptor levels and expression can also occur in earlier stages or even when no damage is observed in white matter with MRI.…”
Section: Discussionmentioning
confidence: 99%
“…Glutamate is the central nervous system's main excitatory neurotransmitter, but when present in excess it triggers a chain of negative reactions. Glutamate neurotoxicity's involvement in the pathogenesis of demyelination and neuronal and synaptic damage in MS has been demonstrated on numerous occasions [56]; activated immune cells and astrocytes release large amounts of glutamate, damaging myelin sheaths and axons [57,58], and changes in glutamate levels in these areas have been associated with the later stages of MS, episodes, and secondary progression. An imbalance in glutamate receptor levels and expression can also occur in earlier stages or even when no damage is observed in white matter with MRI.…”
Section: Discussionmentioning
confidence: 99%
“…Both CNS homeostasis and neuroinflammation can be to a large extent controlled by CNS-resident cells such as microglia, a CNS-resident macrophage-like cell population, and astrocytes, the most abundant cells in the CNS. Microglia and astrocytes are emerging as crucial regulators of CNS autoimmunity, and their multi-faceted functions in MS and EAE have been summarized by other reviews [85,86]. The immune-regulating abilities of microglia and astrocytes are primarily ascribed to their responsiveness to cytokines secreted by infiltrating encephalitogenic T cells.…”
Section: Dubs Regulate Cns-resident Cells In Ms/eaementioning
confidence: 99%
“…Mice deficient of OTUB1 selectively in astrocytes do not show abnormalities under physiological conditions but develop more severe EAE [95]. Of note, astrocytes play both protective and detrimental roles in EAE [86]. However, according to the twowave theory of EAE development, astrocytes contribute to EAE, at least in the early stage, by producing leukocyterecruiting molecules [98].…”
Section: Otub1mentioning
confidence: 99%
“…17,97,[150][151][152][153] Vitamin D is a modulator of the immune system, 154,155 hence its mention here, and accumulating evidence suggests vitamin D deficiency is a risk factor for dysregulated Klotho-associated neurodegenerative diseases, the most noteworthy being MS. 9,27,52,97,102,150,152,153,[156][157][158] Multiple Sclerosis MS is an insidious progressive neurodegenerative disease characterized by demyelinated lesions throughout the brain, spinal cord, and optic nerve resulting from immune-mediated attacks against myelin. [159][160][161][162][163][164][165] It is the apotheosis of myelination disorders that affects *2.5 million people around the world [166][167][168] and currently there are no definitive cures. The standard of chronic care, after using steroids for acute episodes, centers on the use of disease modifying therapies (DMTs) that modulate an overactive immune response, such as antibodies against interferon, interleukin, or related T cell targets.…”
Section: Introductionmentioning
confidence: 99%